Panel Discussion: Evaluating the Current Ability for Preclinical Models & Biomarkers to Translate Psychiatric Programs into the Clinic

Time: 9:30 am
day: Conference Day Two


  • Critically analyzing animal models for accelerating translational development of psychedelic and non-psychedelic compounds
  • Deciphering the most promising preclinical systems for assessing therapeutic durability
  • Exploring the advantages and limitations of in vitro models for investigating potential drugs to target mental health disorders